![Jelena Aleksic](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Jelena Aleksic is the Chief Business Officer and founder of PharmEnable Therapeutics Ltd, which was founded in 2016.
Dr. Aleksic is also the founder of GeneAdviser Ltd.
Actieve functies van Jelena Aleksic
Bedrijven | Functie | Begin |
---|---|---|
Pharmenable Ltd.
![]() Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Oprichter | 01-06-2016 |
Eerdere bekende functies van Jelena Aleksic
Bedrijven | Functie | Einde |
---|---|---|
GeneAdviser Ltd.
![]() GeneAdviser Ltd. BiotechnologyHealth Technology GeneAdviser Ltd. operates an online ordering platform for genetic test services. It enables doctors and their local laboratories to find and order tests for rare diseases, cancer treatment and personalized medicine. The company was founded by Jelena Aleksic and Robert Stojnic and is headquartered in Cambridge, the United Kingdom. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
GeneAdviser Ltd.
![]() GeneAdviser Ltd. BiotechnologyHealth Technology GeneAdviser Ltd. operates an online ordering platform for genetic test services. It enables doctors and their local laboratories to find and order tests for rare diseases, cancer treatment and personalized medicine. The company was founded by Jelena Aleksic and Robert Stojnic and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Pharmenable Ltd.
![]() Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Health Technology |